Estrella Immunopharma, Inc.ESLANASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 13.41% |
| Q2 2025 | -163.50% |
| Q1 2025 | -100.36% |
| Q4 2024 | 68.90% |
| Q3 2024 | 14.54% |
| Q2 2024 | -741.50% |
| Q1 2024 | 54.00% |
| Q4 2023 | 45.44% |
| Q3 2023 | -2361.05% |
| Q2 2023 | -20.02% |
| Q1 2023 | 97.70% |
| Q4 2022 | -699.26% |
| Q3 2022 | 67.89% |
| Q2 2022 | -538.27% |
| Q1 2022 | -58.93% |
| Q4 2021 | 1.54% |
| Q3 2021 | -2925.23% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |